Sobi Receives Positive CHMP Opinion for Tryngolza in Severe Hypertriglyceridemia
The EMA’s CHMP adopted a positive opinion recommending an indication extension for Tryngolza (olezarsen) as an adjunct to diet for severe hypertriglyceridemia.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
BRIEF — SOBI Receives Positive CHMP Opinion For Tryngolza
Oct 16 (Reuters) — Swedish Orphan Biovitrum AB (publ): Sobi Receives Positive Chmp Opinion For Tryngolza® (Olezarsen) For The Treatment Of Severe Hypertriglyceridemia (Shtg) Source text: Further company coverage: SOBIV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;)